Clinical Investigation

DOES THE INCREASE IN BODY MASS INDEX CAUSE MORE OBSTETRIC PROBLEMS?
  • Emel Ebru Özçimen
  • Ayla Üçkuyu
  • Serdar Kaya
Turk J Obstet Gynecol 2006; 3: 62-64
Are the criteria of metabolic syndrome associated with pregnancy complications?
  • Banu Dane
  • Fatma Ustaoğlu
  • Yasemin Yıldırım
  • Yasemin Döventaş
  • Cem Dane
  • Ahmet Çetin
  • Mustafa Yenigün
Turk J Obstet Gynecol 2011; 8: 100-106 DOI: 10.5505/tjod.2011.80664
Effects of the morbid obesity and skin incision choices on surgical outcomes in patients undergoing total abdominal hysterectomy
  • Ebru Ersoy
  • Özlem Evliyaoğlu
  • Okyar Erol
  • Ali Özgür Ersoy
  • Mehmet Akif Akgül
  • Ali Haberal
Turk J Obstet Gynecol 2016; 13: 189-195 DOI: 10.4274/tjod.67864 PMID:28913120

Clinical Investigation

Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women
  • Gökçe Anık İlhan
  • Begüm Yıldızhan
Turk J Obstet Gynecol 2019; 16: 164-168 DOI: 10.4274/tjod.galenos.2019.62558 PMID:31673468
The impact of morbid obesity on survival of endometrial cancer
  • Ahmet Barış Güzel
  • Ghanim Khatib
  • Ümran Küçükgöz Güleç
  • Derya Gümürdülü
  • Mehmet Ali Vardar
Turk J Obstet Gynecol 2020; 17: 209-214 DOI: 10.4274/tjod.galenos.2020.83773 PMID:33072426
Assessing lipoxin-mediated inflammatory responses in the second trimester of pregnancy among women with obesity: A comprehensive analysis
  • Önder Otlu
  • Rauf Melekoğlu
  • Tuğba Raika Kıran
  • Feyza İnceoğlu
  • Ayşe Şebnem Erenler
Turk J Obstet Gynecol 2023; 20: 255-263 DOI: 10.4274/tjod.galenos.2023.16678 PMID:38073076
Evaluation of serum neopterin, periostin, Tenascin‐C, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-2 levels in obese pregnant women
  • Rauf Melekoğlu
  • Songül Ünüvar
  • Neşe Başak Türkmen
  • Aslı Çetin
  • Nesibe Zeyveli Çelik
  • Hande Yüce
  • Şeyma Yaşar
Turk J Obstet Gynecol 2022; 19: 257-267 DOI: 10.4274/tjod.galenos.2022.70593 PMID:36511564